Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin in frontotemporal dementia
NCT04115384Phase 2Terminated
- Sponsor
- HealthPartners Institute
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in frontotemporal dementia (FTD), sponsored by HealthPartners Institute. Started Sep 2019; status: terminated.
02
Drugs
human insulin
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT04115384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04115384.